|
OSTX OS Therapies Inc 1795091 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-10,396,831.00 |
| Balance Sheet |
|
Current Assets
|
$917,552.00 |
|
Assets
|
$7,299,236.00 |
|
Current Liabilities
|
$16,952,769.00 |
|
Liabilities
|
$17,052,769.00 |
|
Equity
|
$-10,824,238.00 |
|
Shares Out
|
39278192.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,563,538.00 |
|
Investing Cash Flow
|
$-466,423.00 |
| Market Analysis |
Market Cap
|
$61,273,979.52 |
|
Price
|
$1.53 |
|
PB
|
0.52 |
|
EPS
|
-0.27 |
|
FCF
|
$-5,029,961.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:37 |
|
| Apr |
May |
Jun |
| 2026-03-31 |
-0.98 |
|
|
2026-05-18 |
-0.27 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-19 |
-0.19 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-17 |
-0.21 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view OSTX documents filed with the SEC.
OSTX Filings
Clear
